The DOI matches its Crossref record; 56 of the 60 references it cites were found in a registry or an index; 32 of the 58 sources its claims cite were checked for support.
TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet–Induced Insulin Resistance in Skeletal Muscle
Open accessAbstract
Diet-induced insulin resistance (IR) adversely affects human health and life span. We show that muscle-specific overexpression of human mitochondrial transcription factor A (TFAM) attenuates high-fat diet (HFD)–induced fat gain and IR in mice in conjunction with increased energy expenditure and reduced oxidative stress. These TFAM effects on muscle are shown to be exerted by molecular changes that are beyond its direct effect on mitochondrial DNA replication and transcription. TFAM augmented the muscle tricarboxylic acid cycle and citrate synthase facilitating energy expenditure. TFAM enhanced muscle glucose uptake despite increased fatty acid (FA) oxidation in concert with higher β-oxidation capacity to reduce the accumulation of IR-related carnitines and ceramides. TFAM also increased pAMPK expression, explaining enhanced PGC1α and PPARβ, and reversing HFD-induced GLUT4 and pAKT reductions. TFAM-induced mild uncoupling is shown to protect mitochondrial membrane potential against FA-induced uncontrolled depolarization. These coordinated changes conferred protection to TFAM mice against HFD-induced obesity and IR while reducing oxidative stress with potential translational opportunities.
Overview
CoChat Summary
TL;DR
Muscle-specific overexpression of human TFAM in mice increased mtDNA copy number, fat oxidation, energy expenditure, and antioxidant defenses while attenuating high-fat diet–induced fat gain and insulin resistance. The effects involved TCA cycle/β-oxidation remodeling, reduced ROS, altered ETC complexes, and pAMPK/PPARβ/PGC-1α/GLUT4 pathways.
Key findings
- In male FVB mice on a 12-week HFD (60% calories from fat), hTFAM transgenic mice gained less body weight and fat mass than wild-type mice, had higher metabolic rates during day and night, and showed less HFD-induced decline in insulin sensitivity by hyperinsulinemic-euglycemic clamp (GIR and muscle glucose uptake); blood glucose was lower in Tg HFD-fed mice than Wt HFD-fed mice.
- TFAM increased mtDNA copy number and mitochondrial-encoded mRNAs and shifted mitochondrial bioenergetics: higher state 3 respiration with palmitoyl-carnitine/malate and lower with glutamate/malate; higher TCA cycle metabolites, citrate synthase, hexokinase activity, and lactate; lower ATP and creatine phosphate with higher ADP and AMP.
- TFAM lowered mtH2O2 emissions regardless of diet, reduced ROS-mediated DNA damage and GSSG/GSH, and increased SOD2, catalase, and Cyt c; it enhanced complete β-oxidation (lower very long-, long-, and medium-chain acylcarnitines, higher short-chain acylcarnitines, higher LCAD) and prevented the HFD-induced increase in Cer18.
- TFAM remodeled the ETC post-translationally (increased ATPsyn and SUO; decreased ND, CORE1, UCP3, and COX1 with increased ubiquitination), induced mild Δψm uncoupling/protection against FA-induced depolarization, and preserved insulin-stimulated pAKT while increasing pAMPK, PPARβ, PGC-1α, and GLUT4.
Methods
- Generated muscle-specific hTFAM transgenic FVB mice using a muscle-specific creatinine kinase promoter; male Tg and Wt littermates were assigned to chow or HFD for 12 weeks.
- Phenotyping included EchoMRI/DEXA body composition, indirect calorimetry, hyperinsulinemic-euglycemic clamp (120–130 mg/dL for 120 min; 16 mU/kg insulin bolus then 2.5 mU/kg/min), high-resolution respirometry, Amplex Red H2O2 measurement, RT-PCR, Western blots, immunoprecipitation, LC-MS lipid metabolites, NMR energy metabolites, TMRM membrane potential imaging, C2C12 myotube TFAM overexpression ± 0.2 mmol/L palmitate, and 3 μmol/L DNP treatment.
- Statistics used Student t test, one-way ANOVA, two-way ANOVA, or Mann-Whitney rank sum test as appropriate, with significance denoted at *P < 0.05, P < 0.01, *P < 0.001, and P < 0.0001.
Limitations
- Stated: only male animals were used to avoid confounding effects of fluctuating female hormones on outcomes.
- Stated: hTFAM has >70% sequence homology to mouse TFAM and conserved DNA-binding domains, but effects related to species differences cannot be fully excluded.
- Evident: findings are from a transgenic mouse overexpression model and C2C12 myotubes, not human skeletal muscle; several mechanistic links are inferred from associations and cell-line experiments rather than direct causal testing in vivo.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
24 Valid · 3 Not valid · 24 Not checked · 158 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Previous studies (40,43) showed that IR induced by HFD can be mitigated by the elimination of ROS.”
What the sources say
- Disputedcites [40] Lee, 2017, Mitochondrial-targeted catalase protects against high-fat diet-induced muscle insulin resistance by decreasing intramuscular lipid accumulation, Diabetes sourceExperimental — accuracy not yet measured
The Results report that high-fat-diet-fed MCAT mice had lower mitochondrial ROS production and were protected from insulin resistance. But the Discussion explicitly rejects reduced ROS as the direct explanation: mice also developed insulin resistance during acute lipid infusion despite lower ROS, and the authors attribute the difference in insulin action to muscle DAG content. The claim’s proposed mechanism is therefore contrary to the paper’s conclusion. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
- Supportedcites [43] Souto Padron de Figueiredo, 2015, Nox2 mediates skeletal muscle insulin resistance induced by a high fat diet, J Biol Chem source
The Results report that Nox2-null mice were protected against high-fat-diet-induced insulin resistance and did not show the diet-induced rise in skeletal-muscle superoxide seen in wild-type mice. The paper also reports that catalase abrogated insulin-resistance effects in cultured muscle cells. Together, these findings support the claim that reducing ROS can mitigate this insulin resistance. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Every source the paper cites for this claim was checked and supports it.
In the paper
“excessive mitochondrial H2O2 (mtH2O2) emissions following high-fat diet (HFD) results in IR via attenuation of insulin signaling and glucose uptake (3).”
What the sources say
- Supportedcites [3] Anderson, 2009, Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans, J Clin Invest source
The Results (p. 3) report that high-fat-fed rats lacked the normal increase in skeletal-muscle Akt phosphorylation after glucose ingestion, while an antioxidant preserved it. The Results (p. 4) report that reducing mitochondrial H2O2 emission in high-fat-fed mice preserved insulin sensitivity and insulin-stimulated muscle glucose uptake. Together, these findings support the attributed link between excess mitochondrial H2O2 emission, impaired insulin signaling and reduced glucose uptake. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Lipid accumulation in skeletal muscle (7) or metabolic overload in mitochondria (8) have also been shown to occur with IR”
What the sources say
- Supportedcites [7] Yu, 2002, Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle, J Biol Chem source
The paper’s opening section reports a strong relationship between skeletal-muscle insulin resistance and increased intramuscular or intramyocellular triglyceride content. Its Discussion also reports increases in intracellular fatty acyl-CoA and diacylglycerol during lipid-induced insulin resistance. The cited claim is an association, not a claim that triglycerides rose during this experiment. (LLM, conf=0.91)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“maintaining a high abundance of mtDNA and reduced oxidative stress ameliorate age-related IR (6).”
What the sources say
- Partly supportedcites [6] Lanza, 2012, Chronic caloric restriction preserves mitochondrial function in senescence without increasing mitochondrial biogenesis, Cell Metab sourceExperimental — accuracy not yet measured
The Results report that caloric restriction reduced age-related oxidative damage in mouse skeletal muscle. But the Results also state that it did not prevent the age-related decline in mtDNA abundance, and the paper does not establish that either change ameliorates insulin resistance. Its reported outcome is preserved mitochondrial function, not improved insulin resistance (Results and Discussion; page numbers unavailable in our copy). (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“which can regulate catalase (22) and SOD2 (23).”
What the sources say
- Supportedcites [22] Fan, 2017, PPARδ promotes running endurance by preserving glucose source
The Results section (‘PPARδ orchestrates mitochondrial gene networks’) reports that GW treatment highly up-regulated antioxidant-defense genes, including Cat, the catalase gene. In the citing sentence, this source is attached to catalase (22); SOD2 has a separate citation (23). (LLM, conf=0.91)
- Supportedcites [23] Wang, 2010, Peroxisome proliferator-activated receptor delta is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart, Circ Res sourceExperimental — accuracy not yet measured
The citation to this paper is attached to SOD2, not catalase. The Results section reports reduced SOD2 transcript and protein levels after PPARδ deletion in adult hearts, supporting regulation of SOD2. The same section reports that catalase levels were unchanged. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
115 more claims · 7 with their cited sources checked
Create a free account to see all 209 claims and every source verdict.
- It may state two separate claims as one. 69
- Probably not a substantial claim. 33
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discussion
“Decreasing complexes I, II, and IV would lower Δψm but enhanced complex V (ATP synthase) likely enhanced ATP production.”
§ Results
“However, Tg mice had significantly the increased protein expression of ATPsyn and SUO proteins when compared with Wt mice in both the chow and HFD groups (Fig. 5A).”
Citations
Cites
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102 · cited 1×
“Skeletal muscle insulin resistance (IR) is a cardinal feature of T2DM and it is often present years prior to T2DM onset (2).”
BackgroundKoves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · cited 1×
“Lipid accumulation in skeletal muscle (7) or metabolic overload in mitochondria (8) have also been shown to occur with IR, and it has been shown that incomplete b-oxidation contributes to skeletal muscle IR (9).”
BackgroundSelf-citationDecline in skeletal muscle mitochondrial function with aging in humans
Short, K. R., Bigelow, M. L., Kahl, J., Singh, R., Coenen-Schimke, J., Raghavakaimal, S., & Nair, K. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501559102 · Cited by 1,333
Self-citationAnderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253
Holland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232
Mitochondrial transcription factor A regulates mtDNA copy number in mammals
Ekstrand, M. I. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh109 · Cited by 919 · cited 1×
“Mitochondrial transcription factor A (TFAM) is a key regulator of mitochondrial DNA replication, repair, and gene transcription (10).”
Background
Cited by
The integrative biology of type 2 diabetes
Roden, M., & Shulman, G. I. (2019) · Nature · doi:10.1038/s41586-019-1797-8 · Cited by 1,167
Self-citationZhang, Z., Huang, Q., Zhao, D., Lian, F., Li, X., & Qi, W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1112363 · Cited by 211
Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications
Xie, S., Xu, S.-C., Deng, W., & Tang, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01378-8 · Cited by 177
“Besides aging directly impeding FA oxidation, increased insulin contributes to the inactivation of FA oxidation by restricting the activity of major rate-limiting enzymes in cardiomyocytes.(69) Worse of all, the intracellular accumulation of lipids further causes posttranslational modifications of several components t…”
BackgroundHao, L., Zhong, W., Dong, H., Guo, W., Sun, X., Zhang, W., Yue, R., Li, T., Griffiths, A., Ahmadi, A. R., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321548 · Cited by 161
Danan, S., Wang, J., Toan, S., Muid, D., Li, R., Chang, X., & Zhou, H. (2022) · Angiogenesis · doi:10.1007/s10456-022-09835-8 · Cited by 136
Metadata
- Authors
- Koh, J.-H., Johnson, M. L., Dasari, S., LeBrasseur, N. K., Vuckovic, I., Henderson, G. C., Cooper, S. A., Manjunatha, S., Ruegsegger, G. N., Shulman, G. I., Lanza, I. R., & Nair, K. S.
- Affiliations
- Mayo Clinic (US)
- Mayo Clinic Regional Comprehensive Metabolomics Core, Mayo Clinic, Rochester, MN
- Yale University (US)
- Corresponding author
- Nair, K. Sreekumaran
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2019-05-14
- Volume
- 68
- Issue
- 8
- Pages
- 1552-1564
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC6692815
- OpenAlex
- W2944967886
- Cited by
- 92
- References
- 60
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 12 · 2023: 23 · 2022: 14 · 2021: 13 · 2020: 7 · 2019: 2
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-08-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Center for Scientific Review (DK-007198, TRDK-007352, RO1-DK-41973, U24-DK-100469)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- TFAM, insulin resistance, high-fat diet, skeletal muscle, fat oxidation, fatty acid beta-oxidation, energy expenditure, TCA cycle, citrate synthase, glucose uptake, L-carnitine, ceramide, AMPK, PGC-1α, PPARδ, GLUT4, Akt, mitochondrial uncoupling, mitochondrial membrane potential, oxidative stress, obesity, mitochondrial DNA
- MeSH terms
- Animals, Body Composition, DNA-Binding Proteins, Female, High Mobility Group Proteins, Hydrogen Peroxide, Insulin Resistance, Male, Mitochondria, Magnetic Resonance Spectroscopy, Oxidation-Reduction, RNA, Messenger, Blotting, Western, Muscle, Skeletal, Muscle Fibers, Skeletal, Immunoprecipitation, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet–Induced Insulin Resistance in Skeletal Muscle. https://app.cochat.ai/papers/10.2337/db19-0088
- The paper
- Koh, J.-H., Johnson, M. L., Dasari, S., LeBrasseur, N. K., Vuckovic, I., Henderson, G. C., Cooper, S. A., Manjunatha, S., Ruegsegger, G. N., Shulman, G. I., Lanza, I. R., & Nair, K. S. (2019). TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet–Induced Insulin Resistance in Skeletal Muscle. Diabetes. https://doi.org/10.2337/db19-0088
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.